Abstracts and Articles

MASH

The summaries are free for public use. The Chronic Liver Disease Foundation will continue to add and archive summaries of articles deemed relevant to CLDF by the Board of Trustees and its Advisors.

1 10/01/2026

Surveillance for Hepatocellular Carcinoma in Patients at High Risk.

Fowler Kathryn J (KJ);Kamaya Aya (A);Rodgers Shuchi K (SK);Kruse Danielle (D);Bashir Mustafa R (MR);Bhamra Guruveer S (GS);Choi Eun Sun (ES);El Kaffas Ahmed (A);Singal Amit G (AG);Park Hyo Jung (HJ);Chernyak Victoria (V)

2 09/15/2026

Bile Acid Metabolism as a Unifying Readout for Diet, Microbiome Function, and Gastrointestinal Disease.

Dichter Jason (J)

3 09/07/2026

Subclinical liver disease and incident cardiovascular events.

Li Le (L);Wu Lingmin (L);Hu Zhicheng (Z);Liu Limin (L);Zhang Tao (T);Zhou Likun (L);Zhang Zhenhao (Z);Xiong Yulong (Y);Zheng Lihui (L);Ding Ligang (L);Yao Yan (Y)

4 09/05/2026

Hepatocellular carcinoma surveillance in MASLD: from cirrhosis-based screening to personalized risk stratification.

Villani Rosanna (R);Serviddio Gaetano (G)

5 09/04/2026

Enhancing short-term predictions of mortality risk for liver transplant candidates through random survival forests.

Ramon-Gonen Roni (R);Bielopolski Dana (D);Kushnir Shiri (S);Ben-Assuli Ofir (O);Nesher Eviatar (E);Shlomai Amir (A)

6 09/04/2026

Trends in Metabolic and Bariatric Surgery Among Adolescents, 2016-2025.

Rode John B (JB);Inge Thomas H (TH);Wu Allan D (AD);Mangarelli Caren (C);Ryder Justin R (JR)

7 09/04/2026

Emerging role of GLP-1 mono, dual, and triple agonists in the management of MASH-related fibrosis.

Tavaglione Federica (F);Loomba Rohit (R)

8 09/04/2026

Adverse childhood experiences and chronic liver diseases: Dose-response, type-specific associations, and mediation analyses.

Li Ying (Y);Wang Shiyu (S);Peng Nana (N);Wu Shanshan (S);He Jianrong (J);Wu Peng (P);Gao Yanxiao (Y);Sha Feng (F);Yang Zhirong (Z);Tang Jinling (J)

9 09/04/2026

Nonalcoholic Steatohepatitis (NASH) and Nonalcoholic Fatty Liver Disease (NALFD) in Pregnancy: A Narrative Review.

Sward Lindsey B (LB);Phillips Amy M (AM);Thurlby Anna C (AC);Cooper Jasmine (J);Wagner Tommy W (TW);Magann Everett F (EF)

10 09/04/2026

Procedure-specific outcomes of robotic versus laparoscopic Roux-en-Y gastric bypass and biliopancreatic diversion with duodenal switch across a decade of MBSAQIP adoption.

Hany Mohamed (M);Zidan Mohamed H (MH);Wafa Ala (A);Elmongui Ehab (E);Al-Momani Hazem (H);Hamdan Khaled (K);Hindawi Mahmoud Diaa (MD);Oviedo Rodolfo (R)

11 09/04/2026

Hepatic steatosis as a risk factor for postoperative delirium following hepatectomy: a retrospective cohort study.

Feng Yuerou (Y);Ma Yifan (Y);Duan Yi (Y);Gao Zhifeng (Z)

12 09/04/2026

Trends in GLP-1 Receptor Agonist Prescriptions for Children Ages 8 to 11 With Obesity: 2019-2026.

Orandi Babak J (BJ);Patel Suhani S (SS);Messito Mary Jo (MJ);Mankowski Michal A (MA);Segev Dorry L (DL);Massie Allan B (AB)

13 09/03/2026

Dietary one-carbon metabolism nutrients and risk of MASLD progression: a prospective cohort study.

Shen Lijun (L);Wang Kai (K);Li Renjie (R);Li Yafang (Y);Guo Yunchong (Y);Li Fangping (F);Yuan Jinqiu (J);Yang Zhen (Z);Xia Bin (B);Lin Xiahong (X)

14 09/03/2026

Medical therapy of MASLD - consequences of the paradigm shift from histology to non-invasive tests.

Messer Eva Katharina (EK);Petroff David (D);Sugimoto Katsutoshi (K);Newsome Philip N (PN);Moriyasu Fuminori (F);Shalimar ();Burgio Marco Dioguardi (MD);Voican Cosmin Sebastian (CS);Vilgrain Valérie (V);de Lédinghen Victor (V);Jesper Daniel (D);Baumeler Stephan (S);Strobel Deike (D);Chan Wah Kheong (WK);Grant Edward G (EG);Perlemuter Gabriel (G);Kelahan Linda C (LC);Cardoso Ana-Carolina (AC);Gabriel Helena (H);Aggarwal Sandeep (S);Choi Byung Ihn (BI);Eddowes Peter J (PJ);Nishimura Takashi (T);Allison Michael (M);Iijima Hiroko (H);Tsochatzis Emmanuel (E);Dubinsky Theodore J (TJ);Anstee Quentin M (QM);Gao Jing (J);Sheridan David (D);Lee Dong Ho (DH);Cobbold Jeremy F (JF);Lee Jae Young (JY);Naveau Sylvie (S);Zhao Yanan (Y);Semela David (D);Huang Pintong (P);Lai-Hung Wong Grace (G);Zeng Jie (J);Wai-Sun Wong Vincent (V);Lim Adrian (A);Villela-Nogueira Cristiane A (CA);Xie Xiaoyan (X);Garg Harshit (H);Barr Richard G (RG);Cantisani Vito (V);Ferraioli Giovanna (G);Sakamaki Kentaro (K);Itoi Takao (T);Kage Masayoshi (M);Yano Hirohisa (H);Blank Valentin (V);Wiegand Johannes (J);Karlas Thomas (T)

15 09/03/2026

Prognostic value of liver histology in steatotic liver disease: a systematic literature review and meta-analysis.

Barritt A Sidney (AS);Qasim Anila (A);Kim Yestle (Y);Miller Sally D (SD);O'Donnell John (J);Johnston Karissa (K)

16 09/02/2026

Clinical utility of a 30% reduction in VCTE-derived liver stiffness measurement for identifying histologic improvement in MASH.

Loomba Rohit (R);Chen Ruiqiu (R);Wang Youxin (Y);Bettencourt Ricki (R);Madamba Egbert (E);Tesfai Kaleb (K);Richards Lisa (L);Muthiah Mark (M);Tan Eunice (E);Young Dan Yock (DY);Gottwald Mildred D (MD);Feng Shibao (S);Margalit Maya (M);Huang Daniel Q (DQ)

17 09/02/2026

Comparative performance of HCC risk scores in identifying low-risk patients with cirrhosis: A multicenter cohort study.

Moussa Mohamed (M);de Wit Koos (K);Baak Lubbertus C (LC);Sprengers Dave (D);Maan Raoel (R);van der Meer Adriaan J (AJ);van Wijk Stan (S);Kleij Emma (E);Dwarkasing Roy S (RS);Brouwer Willem Pieter (WP);Dirksmeier-Harinck Femme (F);Feld Jordan J (JJ);Janssen Harry L A (HLA);Takkenberg R Bart (RB);Sonneveld Milan J (MJ)

18 09/02/2026

Diagnostic performance of ultrasound-derived fat fraction for detecting hepatic steatosis in patients with tumor-related liver disease.

Jiang Danni (D);Qu Chao (C);Jiang Dandan (D);Bao Zhenghao (Z);He Bing (B);Gao Yuxiu (Y);Yao Jingtong (J);Li Shuao (S);Cao Jingyu (J);Zhao Cheng (C)